SEB Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
SEB Asset Management's BMY Position: Q3 2026 in Review
SEB Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 22% in Q3 2026, selling an estimated $39.6M and leaving 2,245,558 shares worth $140M. The position accounts for 0.52% of the portfolio, ranked #28.
SEB Asset Management first reported a position in BMY in Q1 2026 and has held it in 3 quarters since. The position peaked at $218M in Q1 2026. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- SEB Asset Management held 2,245,558 shares of Bristol-Myers Squibb worth $140M as of Q3 2026.
- SEB Asset Management sold 627,074 Bristol-Myers Squibb shares in Q3 2026, an estimated $39.6M.
- Bristol-Myers Squibb made up 0.52% of SEB Asset Management's portfolio in Q3 2026, its #28 holding.
- SEB Asset Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 3 quarters since.
- SEB Asset Management's Bristol-Myers Squibb position peaked at $218M in Q1 2026.
- 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.